Collectively, these data suggested that FOXM1 could regulate the cell cycle and its inhibition caused G2/M arrest, indicating that FOXM1 could be a molecular target to inhibit cell proliferation, especially in AFP-positive HCC. Here, AFP is linked to hepatocellular carcinoma.